Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Martek Biosciences: Worth Revisiting
Seeking Alpha
Sunday, July 12, 2009 - 9:59am
tags:
Martek Biosciences
Blood Thinner's Approval A Muted Win For Lilly
Forbes
Saturday, July 11, 2009 - 8:52am
tags:
blood thinners, Effient, Eli Lilly, Daiichi Sankyo, black box, FDA
Vertex Pulls a Wimpy
Motley Fool
Saturday, July 11, 2009 - 8:51am
tags:
Vertex Pharmaceuticals
Pharmas, Hospitals Fall Due to Health Care Reform Troubles
Seeking Alpha
Saturday, July 11, 2009 - 8:43am
tags:
healthcare reform, Abbott Laboratories, JNJ, Eli Lilly, Merck, Pfizer
Merck Strong in Cardiovasculars
Yahoo/Zacks.com
Saturday, July 11, 2009 - 8:35am
tags:
Merck, Portola Pharmaceuticals, Schering Plough, Zetia, Vernakalant, Cardiome, Vytorin
Par Gets Tentative Approval For Once-Daily Tramadol Generic
WSJ Online
Friday, July 10, 2009 - 10:07am
tags:
Par Pharmaceutical, Tramadol, generics
Bristol exec hints of Onglyza launch strategy
Fierce Pharma
Friday, July 10, 2009 - 9:40am
tags:
Bristol-Myers Squibb, Onglyza, AstraZeneca
Endo Pharma In Licensing Deal For Bioniche's Bladder-Cancer Drug
WSJ Online
Friday, July 10, 2009 - 9:31am
tags:
Endo, bladder cancer, licensing, Bioniche Pharma, Urocidin
Why Healthcare Is a Good Defensive Sector
Seeking Alpha
Friday, July 10, 2009 - 9:28am
tags:
JNJ, Merck, Pfizer
Johnson & Johnson Completes Acquisition of Cougar Biotechnology
Yahoo
Friday, July 10, 2009 - 9:26am
tags:
JNJ, M&A, Cougar Biotechnology
Human Genome Sciences' anthrax drug works in tests
Yahoo/AP
Friday, July 10, 2009 - 8:53am
tags:
Human Genome Sciences, anthrax, ABthrax
What's a Biodollar Worth? Let's Ask Vertex
InVivo
Friday, July 10, 2009 - 8:51am
tags:
Vertex Pharmaceuticals, Telaprevir
[video]Mad About Options: Celgene Flashback
TheStreet.com
Friday, July 10, 2009 - 8:48am
tags:
options, Celgene
Swine Flu Update: Vaccine for Kids, Tamiflu Resistance
WSJ Online
Friday, July 10, 2009 - 8:19am
tags:
swine flu, vaccines, Tamiflu, H1N1
Pfizer plans to appeal Canada ruling on Norvasc
Yahoo/AP
Friday, July 10, 2009 - 8:17am
tags:
Pfizer, Canada, Norvasc, antihypertensives
Ranbaxy Expects FDA Response on Drug Ban ‘Very Soon’
Bloomberg
Friday, July 10, 2009 - 8:15am
tags:
Ranbaxy, FDA
Merck HIV drug Isentress gets full US approval
Yahoo/AP
Thursday, July 9, 2009 - 10:58pm
tags:
HIV, Merck, Isentress, FDA
MAP Pharma says AstraZeneca ends partnership on pediatric asthma drug unit dose budesonide
Yahoo/AP
Thursday, July 9, 2009 - 10:57pm
tags:
MAP Pharmaceuticals, AstraZeneca, partnerships, asthma
Options: Bearish Bet on Wyeth
TheStreet.com
Thursday, July 9, 2009 - 10:56pm
tags:
Wyeth
Merck shares fall after analyst rumor over Zetia
Yahoo/AP
Thursday, July 9, 2009 - 10:45pm
tags:
Merck, Abbott Laboratories, Schering Plough, Zetia, cholesterol

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.